Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
OMCL's Cash to Debt is ranked higher than
86% of the 2078 Companies
in the Global Health Information Services industry.

( Industry Median: 5.21 vs. OMCL: No Debt )
OMCL' s 10-Year Cash to Debt Range
Min: 0.42   Max: No Debt
Current: No Debt

Equity to Asset 0.69
OMCL's Equity to Asset is ranked higher than
76% of the 2008 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. OMCL: 0.69 )
OMCL' s 10-Year Equity to Asset Range
Min: -0.57   Max: 0.78
Current: 0.69

-0.57
0.78
Interest Coverage No Debt
OMCL's Interest Coverage is ranked higher than
85% of the 1364 Companies
in the Global Health Information Services industry.

( Industry Median: 2350.48 vs. OMCL: No Debt )
OMCL' s 10-Year Interest Coverage Range
Min: 44.6   Max: 2381.5
Current: No Debt

44.6
2381.5
F-Score: 5
Z-Score: 5.54
M-Score: -2.26
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 11.09
OMCL's Operating margin (%) is ranked higher than
83% of the 2062 Companies
in the Global Health Information Services industry.

( Industry Median: 5.48 vs. OMCL: 11.09 )
OMCL' s 10-Year Operating margin (%) Range
Min: -29   Max: 9.27
Current: 11.09

-29
9.27
Net-margin (%) 6.61
OMCL's Net-margin (%) is ranked higher than
78% of the 2062 Companies
in the Global Health Information Services industry.

( Industry Median: 3.74 vs. OMCL: 6.61 )
OMCL' s 10-Year Net-margin (%) Range
Min: -30.86   Max: 20.32
Current: 6.61

-30.86
20.32
ROE (%) 7.69
OMCL's ROE (%) is ranked higher than
73% of the 2001 Companies
in the Global Health Information Services industry.

( Industry Median: 7.10 vs. OMCL: 7.69 )
OMCL' s 10-Year ROE (%) Range
Min: -28.06   Max: 28.62
Current: 7.69

-28.06
28.62
ROA (%) 5.42
OMCL's ROA (%) is ranked higher than
77% of the 2086 Companies
in the Global Health Information Services industry.

( Industry Median: 3.75 vs. OMCL: 5.42 )
OMCL' s 10-Year ROA (%) Range
Min: -7.04   Max: 17.93
Current: 5.42

-7.04
17.93
ROC (Joel Greenblatt) (%) 59.20
OMCL's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 2071 Companies
in the Global Health Information Services industry.

( Industry Median: 28.79 vs. OMCL: 59.20 )
OMCL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -113.41   Max: 141.68
Current: 59.2

-113.41
141.68
Revenue Growth (%) 17.00
OMCL's Revenue Growth (%) is ranked higher than
88% of the 1669 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. OMCL: 17.00 )
OMCL' s 10-Year Revenue Growth (%) Range
Min: -53.3   Max: 17.5
Current: 17

-53.3
17.5
EBITDA Growth (%) 39.70
OMCL's EBITDA Growth (%) is ranked higher than
93% of the 1370 Companies
in the Global Health Information Services industry.

( Industry Median: 7.20 vs. OMCL: 39.70 )
OMCL' s 10-Year EBITDA Growth (%) Range
Min: -14.1   Max: 124.1
Current: 39.7

-14.1
124.1
EPS Growth (%) 64.70
OMCL's EPS Growth (%) is ranked higher than
95% of the 1278 Companies
in the Global Health Information Services industry.

( Industry Median: 8.40 vs. OMCL: 64.70 )
OMCL' s 10-Year EPS Growth (%) Range
Min: -69.7   Max: 260.9
Current: 64.7

-69.7
260.9
» OMCL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

OMCL Guru Trades in Q4 2013

Joel Greenblatt 72,226 sh (New)
Paul Tudor Jones 19,574 sh (New)
Steven Cohen Sold Out
» More
Q1 2014

OMCL Guru Trades in Q1 2014

Paul Tudor Jones 14,400 sh (-26.43%)
Joel Greenblatt 45,947 sh (-36.38%)
» More
Q2 2014

OMCL Guru Trades in Q2 2014

Jim Simons 103,943 sh (New)
Ken Fisher 410,000 sh (New)
Paul Tudor Jones 16,552 sh (+14.94%)
Joel Greenblatt 43,389 sh (-5.57%)
» More
Q3 2014

OMCL Guru Trades in Q3 2014

Paul Tudor Jones 24,905 sh (+50.47%)
Ken Fisher 492,478 sh (+20.12%)
Jim Simons 90,443 sh (-12.99%)
Joel Greenblatt 35,084 sh (-19.14%)
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2014-09-30 Add 20.12%$26.24 - $29.72 $ 32.1818%492478
Ken Fisher 2014-06-30 New Buy0.03%$25.2 - $29.19 $ 32.1819%410000
Joel Greenblatt 2014-03-31 Reduce -36.38%0.02%$25.02 - $30.27 $ 32.1818%45947
Joel Greenblatt 2013-12-31 New Buy0.04%$22.41 - $25.59 $ 32.1835%72226
Joel Greenblatt 2012-09-30 Sold Out 0.1%$12.79 - $14.97 $ 32.18126%0
Joel Greenblatt 2012-06-30 Add 98.26%0.05%$12.87 - $15.36 $ 32.18126%92061
Joel Greenblatt 2012-03-31 New Buy0.06%$14.22 - $17.85 $ 32.18117%46435
George Soros 2011-12-31 Sold Out 0.0037%$13.05 - $17.05 $ 32.18108%0
George Soros 2011-09-30 Add 25%$13.2 - $17.11 $ 32.18108%15500
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 41.90
OMCL's P/E(ttm) is ranked higher than
73% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 58.20 vs. OMCL: 41.90 )
OMCL' s 10-Year P/E(ttm) Range
Min: 8.94   Max: 795.88
Current: 41.9

8.94
795.88
P/B 3.00
OMCL's P/B is ranked higher than
69% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 3.38 vs. OMCL: 3.00 )
OMCL' s 10-Year P/B Range
Min: 0.96   Max: 13.68
Current: 3

0.96
13.68
P/S 2.80
OMCL's P/S is ranked higher than
66% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 2.60 vs. OMCL: 2.80 )
OMCL' s 10-Year P/S Range
Min: 0.94   Max: 5.54
Current: 2.8

0.94
5.54
PFCF 49.30
OMCL's PFCF is ranked higher than
74% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 84.60 vs. OMCL: 49.30 )
OMCL' s 10-Year PFCF Range
Min: 8   Max: 730
Current: 49.3

8
730
EV-to-EBIT 21.78
OMCL's EV-to-EBIT is ranked higher than
75% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 34.56 vs. OMCL: 21.78 )
OMCL' s 10-Year EV-to-EBIT Range
Min: -1140.1   Max: 424.9
Current: 21.78

-1140.1
424.9
PEG 0.90
OMCL's PEG is ranked higher than
94% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. OMCL: 0.90 )
OMCL' s 10-Year PEG Range
Min: 0.5   Max: 42.93
Current: 0.9

0.5
42.93
Shiller P/E 81.50
OMCL's Shiller P/E is ranked higher than
79% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. OMCL: 81.50 )
OMCL' s 10-Year Shiller P/E Range
Min: 15.61   Max: 299.13
Current: 81.5

15.61
299.13
Current Ratio 2.41
OMCL's Current Ratio is ranked higher than
75% of the 2043 Companies
in the Global Health Information Services industry.

( Industry Median: 1.91 vs. OMCL: 2.41 )
OMCL' s 10-Year Current Ratio Range
Min: 0.64   Max: 5.21
Current: 2.41

0.64
5.21
Quick Ratio 2.12
OMCL's Quick Ratio is ranked higher than
73% of the 2043 Companies
in the Global Health Information Services industry.

( Industry Median: 1.78 vs. OMCL: 2.12 )
OMCL' s 10-Year Quick Ratio Range
Min: 0.4   Max: 4.95
Current: 2.12

0.4
4.95

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 50.30
OMCL's Price/Net Current Asset Value is ranked higher than
76% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. OMCL: 50.30 )
OMCL' s 10-Year Price/Net Current Asset Value Range
Min: 2.48   Max: 271
Current: 50.3

2.48
271
Price/Tangible Book 6.70
OMCL's Price/Tangible Book is ranked higher than
70% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 8.40 vs. OMCL: 6.70 )
OMCL' s 10-Year Price/Tangible Book Range
Min: 1.2   Max: 16.59
Current: 6.7

1.2
16.59
Price/DCF (Projected) 2.10
OMCL's Price/DCF (Projected) is ranked higher than
80% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 8.40 vs. OMCL: 2.10 )
OMCL' s 10-Year Price/DCF (Projected) Range
Min: 0.94   Max: 8.67
Current: 2.1

0.94
8.67
Price/Median PS Value 1.20
OMCL's Price/Median PS Value is ranked higher than
66% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 1.18 vs. OMCL: 1.20 )
OMCL' s 10-Year Price/Median PS Value Range
Min: 0.22   Max: 2.2
Current: 1.2

0.22
2.2
Price/Peter Lynch Fair Value 1.70
OMCL's Price/Peter Lynch Fair Value is ranked higher than
92% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. OMCL: 1.70 )
OMCL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.69   Max: 23.38
Current: 1.7

0.69
23.38
Price/Graham Number 3.50
OMCL's Price/Graham Number is ranked higher than
78% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 27.59 vs. OMCL: 3.50 )
OMCL' s 10-Year Price/Graham Number Range
Min: 1.29   Max: 18.72
Current: 3.5

1.29
18.72
Earnings Yield (Greenblatt) 4.60
OMCL's Earnings Yield (Greenblatt) is ranked higher than
73% of the 2056 Companies
in the Global Health Information Services industry.

( Industry Median: 3.80 vs. OMCL: 4.60 )
OMCL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 15.9
Current: 4.6

0.2
15.9
Forward Rate of Return (Yacktman) 44.50
OMCL's Forward Rate of Return (Yacktman) is ranked higher than
97% of the 1069 Companies
in the Global Health Information Services industry.

( Industry Median: 13.07 vs. OMCL: 44.50 )
OMCL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.1   Max: 45
Current: 44.5

-5.1
45

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:OC9.Germany,
Omnicell, Inc., is a Delaware corporation incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company is a provider of automation and business information solutions enabling healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. The Company's automation, analytics and medication adherence solutions in hospitals and longer-term care environments are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and are intended to enhance patient safety, reduce medication errors, reduce operating costs, improve workflow, and increase operational efficiency. Approximately 6,000 hospitals, institutional pharmacies, and retail pharmacies use Company's products worldwide. The Company is organized into two operating business segments: Acute Care, which primarily includes products and services sold to hospital customers, and Non-Acute Care, which primarily includes products and services sold to customers outside of the hospital setting. In acute care facilities, its solutions use advanced, software‑based medication control and tracking algorithms that interact with hardware security features, resulting in a system that provides both the pharmacist and the nurse real-time safety controls. It also provides medication bar code verification at every step of the medication administration process, from entry to the hospital through the administration of the medication to a patient. Its systems enables customers to reduce or eliminate inefficiencies such as manual tracking and reconciliations, nursing time spent in obtaining medications and in performing inventory control and extraneous process steps. Similar to its medication solutions, Company's medical and surgical supply systems provide hospitals control over consumable supplies critical to providing quality healthcare. Its solutions provide inventory control software that is designed to ensure critical supplies are always stocked in the right locations. It also offers analytics and reporting software for pharmacists and material managers to more easily manage inventory flow, tracking and optimization. The Non-Acute Care segment represents products sold outside the hospital setting and includes medication adherence products sold under the brand name of MTS, and dispensing systems sold under the Omnicell brand. The MTS products consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities. These systems use consumable medication punch cards and specialized machines that allow the pharmacies to automatically or semi-automatically assemble, fill and seal drugs into
» More Articles for OMCL

Headlines

Articles On GuruFocus.com
Ken Fisher's Top 5 New Portfolio Stocks Jul 27 2014 
comment on OMCL May 26 2013 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 1,250 Shares Feb 03 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 24 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 12 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 937 Shares Jan 05 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 3,351 Shares Dec 22 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 1,500 Shares Dec 03 2010 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 4,265 Shares Nov 30 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,372 Shares Oct 22 2010 

More From Other Websites
Omnicell Reveals "Take on Tomorrow" Initiative at ASHP Mid-Year Meeting Dec 04 2014
Omnicell Reveals "Take on Tomorrow" Initiative at ASHP Mid-Year Meeting Dec 04 2014
Don't Miss Today's Strong And Under The Radar Stock: Omnicell (OMCL) Nov 26 2014
Omnicell To Present At The 26th Annual Piper Jaffray Health Care Conference Nov 25 2014
Omnicell To Present At The 26th Annual Piper Jaffray Health Care Conference Nov 25 2014
3 Innovative Names To Watch In Medical Technology Nov 19 2014
Omnicell Offers Advanced OT Automation at Hospital in Riyadh Nov 19 2014
OMNICELL, INC Financials Nov 19 2014
Omnicell and King Faisal Specialist Hospital and Research Centre Collaborate to Deliver Excellence... Nov 18 2014
Omnicell and King Faisal Specialist Hospital and Research Centre Collaborate to Deliver Excellence... Nov 18 2014
10-Q for Omnicell, Inc. Nov 13 2014
Omnicell Reports Mixed Q3, Positive on Surgichem Buyout Nov 11 2014
OMNICELL, INC Files SEC form 10-Q, Quarterly Report Nov 10 2014
OMNICELL, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Nov 07 2014
Omnicell Earnings Hit by High Tax, User Addition Aids Sales Nov 07 2014
Omnicell Launches Its First Fully Automated Multimed Packing Solution, Driving Workflow Efficiency,... Nov 05 2014
Omnicell To Present At The 2014 Stephens Inc. Fall Investment Conference Nov 05 2014
Omnicell To Present At The 2014 Stephens Inc. Fall Investment Conference Nov 05 2014
Omnicell Launches Its First Fully Automated Multimed Packing Solution, Driving Workflow Efficiency,... Nov 05 2014
Saratoga Hospital Selects Omnicell Unity Enterprise Platform to Upgrade Existing Medication... Nov 04 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK